There seems to be an understanding among companies developing coronavirus vaccines that the more candidates that are proven safe and effective, the better. But that doesn't mean the options won't be compared to each other, and it looks like Moderna — which on Monday announced its late-stage trial found its vaccine to be nearly 95 percent effective — has a key advantage over Pfizer.
Yes, Moderna's numbers are a little better and the data released were more comprehensive, but Pfizer's 90 percent rate still squashed expectations and is considered very promising. Where Moderna really seems to have a leg up is on the distribution front. Should Moderna get Food and Drug Administration approval in the United States, as well as the green light elsewhere, it will likely be easier to store than Pfizer's vaccine, which requires ultra-cold freezers to maintain stability. Moderna's candidate, meanwhile, "can be distributed using existing cold-chain shipping and storage infrastructure," Reuters reports, and can remain stable in a regular refrigerator for as long as 30 days, exceeding expectations.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
Sniper kills 2 Idaho firefighters in ambushSpeed Read A man started a wildfire, then fired a rifle at first responders when they arrived
-
Senate advances GOP bill that costs more, cuts moreSpeed Read The bill would make giant cuts to Medicaid and food stamps, leaving 11.8 million fewer people with health coverage
-
June 30 editorial cartoonsCartoons Monday’s political cartoons include Jeff Bezos' wedding, mixed signals from the Democratic party, RFK Jr. denying vaccines, and a love-struck Donald Trump
-
Kennedy's vaccine panel signals skepticism, changeSpeed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panelspeed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kidsSpeed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sickspeed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last yearspeed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive orderspeed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts
-
RFK Jr. visits Texas as 2nd child dies from measlesSpeed Read An outbreak of the vaccine-preventable disease continues to grow following a decade of no recorded US measles deaths
-
Shingles vaccine cuts dementia risk, study findsSpeed Read Getting vaccinated appears to significantly reduce the chances of developing Alzheimer's and other forms of dementia
